(Total Views: 836)
Posted On: 08/08/2020 12:27:12 PM
Post# of 153911
Agree on all fronts. My big concern is the timeline and letting Regeneron et al. catch up.
I know the results will be very good, and quite possibly not good enough to merit EUA. So then we're either banking on the S/C results in probably November, or a very long slog in m2m enrollment.
In the meantime, we will continue to be hammered by shorts. Share price will likely fall in my opinion with newer investors spooked by a drawn-out timeline. I very much love the potential but I am also concerned that we won't have a significant catalyst other than uplisting for another couple months.
I know the results will be very good, and quite possibly not good enough to merit EUA. So then we're either banking on the S/C results in probably November, or a very long slog in m2m enrollment.
In the meantime, we will continue to be hammered by shorts. Share price will likely fall in my opinion with newer investors spooked by a drawn-out timeline. I very much love the potential but I am also concerned that we won't have a significant catalyst other than uplisting for another couple months.
(3)
(2)
